THOUSAND OAKS, Calif., Feb. 2, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved TEZSPIRE® (tezepelumab-ekko) for ...
The new prefilled, single-use pen is provided as 210mg/1.91mL (110mg/mL) for subcutaneous injection into the thigh or abdomen. The Food and Drug Administration (FDA) has approved a new prefilled, ...
Please provide your email address to receive an email when new articles are posted on . The FDA has expanded approval of the single-dose Dupixent pre-filled pen for use in children aged as young as 2 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The recommendation is for the second injection option of ...